APA (7th ed.) Citation

AK, P., MV, D., S, P., S, B., KM, W., RM, S., . . . J, B. (2003). Single injection of CD34+ progenitor-derived dendritic cell vaccine can lead to induction of T-cell immunity in patients with stage IV melanoma. Journal of immunotherapy (Hagerstown, Md. : 1997), 26(5), 432. https://doi.org/10.1097/00002371-200309000-00006

Chicago Style (17th ed.) Citation

AK, Palucka, Dhodapkar MV, Paczesny S, Burkeholder S, Wittkowski KM, Steinman RM, Fay J, and Banchereau J. "Single Injection of CD34+ Progenitor-derived Dendritic Cell Vaccine Can Lead to Induction of T-cell Immunity in Patients with Stage IV Melanoma." Journal of Immunotherapy (Hagerstown, Md. : 1997) 26, no. 5 (2003): 432. https://doi.org/10.1097/00002371-200309000-00006.

MLA (9th ed.) Citation

AK, Palucka, et al. "Single Injection of CD34+ Progenitor-derived Dendritic Cell Vaccine Can Lead to Induction of T-cell Immunity in Patients with Stage IV Melanoma." Journal of Immunotherapy (Hagerstown, Md. : 1997), vol. 26, no. 5, 2003, p. 432, https://doi.org/10.1097/00002371-200309000-00006.